StreetInsider.com Unusual 11 Mid-Day Movers 08/22/2007

August 22, 2007 11:45 AM EDT

Hana Biosciences (Nasdaq: HNAB) 27.2% HIGHER; Announced that Marqibo has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Philadelphia chromosome negative acute lymphoblastic leukemia (ALL) in second relapse or who have failed two lines of prior therapy. Earlier this year, Marqibo was also granted Orphan Drug Designation by the FDA for the treatment of adult ALL.

Tween Brands, Inc. (NYSE: TWB) 25% LOWER; Reports Q2 EPS of $0.07 vs. consensus of $0.15. Revenues were $213.7 million vs. $211.87 million consensus. The company also lowered its outlook. As a result of Tween Brands\' lower second quarter earnings and revised outlook on the third and fourth quarters, the company expects full-year earnings per diluted share of $1.80 to $1.95 compared to its previous guidance of $2.10 to $2.25. (Consensus is $2.23). Separately, Wachovia downgrades Tween Brands to Market Perform.

ABATIX CORP. (Nasdaq: ABIX) 20.75% LOWER; Said it intends to file a Form 25 with The NASDAQ Stock Market and the Securities and Exchange Commission to voluntarily delist is Common Stock from the NASDAQ Capital Market and to deregister the Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended. The Company also intends to file a Form 15 with the SEC to voluntarily suspend reporting obligations under Section 15(d) of the Exchange Act. The Company anticipates that the Common Stock will be quoted on the Pink Sheets.

Blue Coat (Nasdaq: BCSI) 20% HIGHER; Reports Q1 earnings of $0.43 per share, 8 cents better than estimates. Revenues came in at $62.4 million versus the consensus of $58.8 million. Sees Q2 EPS of $0.43-$0.50, ex-items, versus the consensus of $0.36. Sees Q2 revenues of $67-$70 million versus the consensus of $61.65 million.

Bally Technologies (NYSE: BYI) 16.3% HIGHER; Reiterates its previous guidance and expects its fiscal 2007 revenues will be in the range of $670 million to $690 million. (Consensus is $683.86 million). The company expects that diluted earnings per share will exceed $0.34, and that adjusted diluted earnings per share after adding back stock-based compensation will exceed $0.51 for the fiscal year ended June 30, 2007. These results are unaudited and are subject to change. (Consensus is $0.28). The Company expects Diluted EPS of approximately $1.25 to $1.55 and Adjusted EPS of approximately $1.39 to $1.69 for the fiscal year ending June 30, 2008. (Consensus is $1.01)

Nuvelo, Inc. (Nasdaq: NUVO) 12.3% HIGHER; Announced enrollment of the first patient in the SONOMA-3 (Speedy Opening of Non-functional and Occluded catheters with Mini-dose Alfimeprase-3) trial evaluating lead product candidate, alfimeprase, for the treatment of central venous catheter occlusion (CO). "Analysis of data from our previous Phase 3 SONOMA study provided further evidence that alfimeprase is an active thrombolytic which has the potential to dissolve clots quickly and rapidly restore catheter function, however, the dose and concentration we used did not generate results in line with the target product profile we believe necessary for commercial success in this market," said Michael Levy, M.D., executive vice president of research and development. Separately, Brean Murray upgraded Nuvelo to Hold.

Aluminum Corp. of China Ltd. (NYSE: ACH) 12% HIGHER; Shares jump as Chinese markets rise in overnight trading. Company said growth is strong and would look to acquire rivals. Aluminum sector/industry up 3.2% today.

VMware, Inc. (NYSE: VMW) 8.9% HIGHER; Jefferies analyst reiterates a Buy rating, raises price target to $74.

MGM Mirage (NYSE: MGM) 7.8% HIGHER; Dubai World agreed to pay $5 billion for a 9.5% stake in MGM Mirage (NYSE: MGM). Under the deal, Dubai will pay $2.7 billion to acquire its stake in the CityCenter development and will buy 14 million shares from MGM at a prices of $84 per share. Dubai also indicated it could acquire another 14 million shares from shareholders.

The Topps Company, Inc. (Nasdaq: TOPP) 6.6% LOWER; The Upper Deck Company said it terminated its previously announced tender offer for all outstanding shares of The Topps Company, stating that the actions of Topps made the conditions precedent to the tender offer incapable of being satisfied

Broadridge Financial Solutions, Inc. (NYSE: BR) 4.5% LOWER; Reports Q4 EPS of $0.71, 2 cents worse than estimates. Revenues were $774 million vs. $729.25 million consensus. Company reaffirms 2008 financial guidance. Sees EPS between $1.17-1.25 (before one-time transition expenses) vs. consensus of $1.22.

Related Categories

Special Reports

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?